Skip to main content

A PHASE 1 STUDY OF DS-3032B IN COMBINATION WITH QUIZARTINIB IN SUBJECTS WITH FLT3-ITD MUTANT ACUTE MYELOID LEUKEMIA THAT ARE RELAPSED/REFRACTORY, OR NEWLY DIAGNOSED AND UNFIT FOR INTENSIVE CHEMOTHERAPY

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Daiichi Sankyo Inc

Start Date

March 13, 2019

End Date

March 31, 2024
 

Administered By

Duke Cancer Institute

Awarded By

Daiichi Sankyo Inc

Start Date

March 13, 2019

End Date

March 31, 2024